
Moderna stocks almost tripled on Wednesday (August 19) after the pharma giant completed trials of its new cancer vaccine. Called intismeran autogene, the new drug was given alongside Merck’s immunotherapy Keytruda. Researchers have noted that it reduced the chances of high-risk melanoma, a serious type of skin cancer, returning or spreading
Firstpost
Original source
firstpost com
Check live status on DownRightNow

